European Journal of Cancer
Volume 36, Issue 17 , Pages 2215-2220, November 2000

Cervical cancer screening in France

  • P Schaffer

      Affiliations

    • Programme EVE, Strasbourg, France
  • ,
  • H Sancho-Garnier

      Affiliations

    • Université de Montpellier, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-4-67-6130-00; fax: +33-4-67-61-31-16
  • ,
  • M Fender

      Affiliations

    • Programme EVE, Strasbourg, France
  • ,
  • P Dellenbach

      Affiliations

    • Programme EVE, Strasbourg, France
  • ,
  • J.P Carbillet

      Affiliations

    • EVADEC, Besançon, France
  • ,
  • E Monnet

      Affiliations

    • EVADEC, Besançon, France
  • ,
  • G.P Gauthier

      Affiliations

    • APCC25, Besançon, France
  • ,
  • A Garnier

      Affiliations

    • ODLC, Meylan, France

Received 12 May 2000; received in revised form 31 July 2000; accepted 2 August 2000.

Abstract 

In France, as in other European countries the incidence and mortality rates of carcinoma of the cervix uteri indicate a clear decrease in invasive cancers. Opportunistic screening has spread and, presently, approximately 60% of the female population undergo a regular cytological test. This rate increases up to 80% in the younger age groups and decreases to 20% after the age of 60 years. In 1990, intervention procedures were defined at a consensus conference; the major recommendations were to screen all women exclusively by cervical smears, for ages 25–65 years over a 3-year period. Guidelines on the quality control of cervical smear taking and reading were published by the national agency of evaluation of health intervention (ANAES). Since 1990, four population-based, organised pilot programmes, have been implemented in Isère. Doubs, Bas-Rhin and Martinique. These programmes evaluate the participation rate (from approximately 20–80% depending upon the age and the geographical area), the rate of abnormal tests (0.2–3%), according to the laboratories, the cancer detection rate (0.04%–0.15%) and some other quality indicators. Recently (November 1998) a law was passed stipulating that the screening test will be free of charge when performed in agreement with the national recommendations. A specific organisation for cytological quality control will be implemented. An effort to better identify and to include the screening process the women in the population who are not yet participating has to be made.

Keywords:  Cervical cancer screening, France, Opportunistic, Organised, Recommendations, Quality control, Guidelines

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(00)00312-9

European Journal of Cancer
Volume 36, Issue 17 , Pages 2215-2220, November 2000